AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
ASPX was delisted on the 4th of May, 2015.
0 hedge funds and large institutions have $0 invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 138 closing their positions.
100% less funds holding
Funds holding: 138 → 0 (-138)
100% less funds holding in top 10
Funds holding in top 10: 9 → 0 (-9)
100% less capital invested
Capital invested by funds: $1.91B → $0 (-$1.91B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 138
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$446M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$180M |
| 3 |
Millennium Management
New York
|
-$116M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$88.5M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$67.7M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
Teacher Retirement System of Texas
Austin,
Texas
| – | -$56K | -558 | Closed |
|
127
Barclays
London,
United Kingdom
| – | -$48K | -484 | Closed |
|
128
UBS Group
Zurich,
Switzerland
| – | -$30K | -300 | Closed |
|
129
BlackRock
New York
| – | -$26K | -259 | Closed |
|
|
BJ
130
BlackRock Japan
Tokyo,
Japan
| – | -$22K | -220 | Closed |
|
131
BNP Paribas Financial Markets
Paris,
France
| – | -$20.7K | -206 | Closed |
|
132
SEI Investments
Oaks,
Pennsylvania
| – | -$16K | -156 | Closed |
|
|
CCS
133
Crosspoint Capital Strategies
Orinda,
California
| – | -$8K | -78 | Closed |
|
134
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$8K | -78 | Closed |
|
|
MAA
135
Managed Account Advisors
Jersey City,
New Jersey
| – | -$6K | -63 | Closed |
|
|
LTFS
136
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | -$5K | -48 | Closed |
|
137
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$4K | -35 | Closed |
|
|
FNYS
138
First New York Securities
New York
| – | -$3.11K | -31 | Closed |
|
ASPX Hedge Fund Activity: Q2 2015 in Review
0 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q2 2015, worth a combined $0 — down 100% from $1.91B a quarter earlier.
Sellers outnumbered buyers: 138 funds closed out of ASPX and 0 opened new positions — a net loss of 138 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Deerfield Management, exiting entirely with an estimated $446M sold.
- 0 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q2 2015, down from 138 in Q1 2015.
- Funds reported $0 of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q2 2015, down 100% quarter-over-quarter.
- 0 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q2 2015 and 138 closed out, a net change of -138 holders.
- The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q2 2015 was Deerfield Management, an estimated $446M sold.
Based on aggregated 13F filings for Q2 2015.